LUND, SE / ACCESS Newswire / September 12, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, ...
LUND, SE / ACCESS Newswire / October 21, 2025 / Alligator Bioscience (Nasdaq Stockholm: ATORX)(STO:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody ...
The research involves patients with advanced solid malignancies on tumour-directed therapy The research involves patients with advanced solid malignancies on tumour-directed therapy Alligator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results